No Result
View All Result
Global Finances Daily
  • Alternative Investments
  • Crypto
  • Financial Markets
  • Investments
  • Lifestyle
  • Protection
  • Retirement
  • Savings
  • Work & Careers
No Result
View All Result
  • Alternative Investments
  • Crypto
  • Financial Markets
  • Investments
  • Lifestyle
  • Protection
  • Retirement
  • Savings
  • Work & Careers
  • Login
Global Finances Daily
No Result
View All Result
Home Alternative Investments

Pimco purchases Blue Owl BDC’s $400m bond offering

April 15, 2026
in Alternative Investments
0
Pimco buys $400m of bonds issued by Blue Owl BDC


Pimco has purchased all of the $400m (£295m) of bonds issued by Blue Owl Capital for its private credit fund on Monday (13 April).

The bonds, which are set to mature in 2028, were issued by the firm’s listed company Blue Owl Capital Corp (OBDC), and were offered at a 6.5 per cent yield.

The news that Pimco has bought the bonds was first reported by Bloomberg and has since been verified by Alternative Credit Investor.

According to Bloomberg, Trace data showed that since the sale, one secondary market trade of $5m has occurred.

Blue Owl’s business development companies, and the wider BDC sector, have come under scrutiny recently following a surge in redemption requests which, in turn, has prompted several ratings downgrades.

Read more: Pimco: Secondary trading in private assets may risk illiquidity premium

Shareholders in the Blue Owl Credit Income Corp (OCIC) fund asked to withdraw 21.9 per cent of shares in the three months to 31 March, according to a filing, while investors in the smaller Blue Owl Technology Income Corp (OTIC) sought to redeem 40.7 per cent of shares.

Blue Owl has since sought to allay fears, issuing a statement on LinkedIn earlier this month attributing the withdrawal requests to “heightened negative sentiment” rather than the vehicles’ performance.

Other private credit investors, including Blackstone, Ares and KKR have also received a surge in redemption requests amid mounting concerns among investors about the disruptive impact of AI on the software sector. Many private credit funds are exposed to software companies, which have experienced share price volatility amid the perceived threat posed by AI.

Pimco and Blue Owl have been contacted by Alternative Credit Investor for comment.

Read more: Private credit weathers scrutiny as managers reject crisis narrative



Editorial Team

Editorial Team

Related Posts

Alternative Credit Awards North America
Alternative Investments

Alternative Credit Awards North America: Winners unveiled!

April 15, 2026
Foresight provides SME lender Revolve with £40m senior debt facility
Alternative Investments

Foresight provides SME funder Revolve with £40m debt facility

April 15, 2026
Asset-based lending remains 'resilient' amid macro uncertainty
Alternative Investments

Asset-based lending remains ‘resilient’ despite global economic uncertainty

April 15, 2026
Bain Capital opens Abu Dhabi office
Alternative Investments

Bain Capital opens Abu Dhabi office following strategic partnership

April 15, 2026
LBP AM European Private Markets hires sales director in Germany
Alternative Investments

LBP AM hires sales director at new Frankfurt office

April 15, 2026
JPMAM: No sign of 'significant deterioration' in credit quality in private credit funds
Alternative Investments

JPMAM: Private credit funds not showing ‘significant deterioration’ in credit quality

April 15, 2026
Load More
Next Post
Associate Director of Employer Relations

Associate Director of Employer Relations

Popular News

  • Are Smartwatches Really Waterproof? | Lifehacker

    Are Smartwatches Really Waterproof? | Lifehacker

    0 shares
    Share 0 Tweet 0
  • Software stocks fall as fear of AI disruption is back in full force

    0 shares
    Share 0 Tweet 0
  • 10 Shows Like ‘Call the Midwife’ You Should Watch Next

    0 shares
    Share 0 Tweet 0
  • The Best Homeowners Insurance in Oklahoma for 2023

    0 shares
    Share 0 Tweet 0
  • Recursion Pharmaceuticals soars 121% after Nvidia invests $50 million in the biotech for AI drug discovery

    0 shares
    Share 0 Tweet 0

Latest News

US Midterm Election Mirrors 2024 with Crypto Moving into Ohio Races

US Midterm Election Mirrors 2024 with Crypto Moving into Ohio Races

April 15, 2026
0

Another political action committee (PAC) aligned with the cryptocurrency industry announced its endorsement for a candidate in Ohio’s Senate race,...

Is Tesla a chip stock now? Investors are cheering a semiconductor milestone.

Is Tesla a chip stock now? Investors are cheering a semiconductor milestone.

April 15, 2026
0

The AI5 chip, which Tesla says will power humanoid robots and supercomputers, has completed a critical step.

Iran Nuclear Deal Bitcoin: The 20-Year Offer

Iran Nuclear Deal Bitcoin: The 20-Year Offer

April 15, 2026
0

Iran nuclear deal bitcoin implications are coming into focus as the US has proposed a 20-year pause on Iran’s nuclear...

U.S. economy is sagging with war in Iran a major source of uncertainty for business, Fed’s ‘beige book’ finds

U.S. economy is sagging with war in Iran a major source of uncertainty for business, Fed’s ‘beige book’ finds

April 15, 2026
0

U.S. businesses are pulling back from making major decisions due to uncertainty stemming from the war with Iran, according to...

Global Finances Daily

Welcome to Global Finances Daily, your go-to source for all things finance. Our mission is to provide our readers with valuable information and insights to help them achieve their financial goals and secure their financial future.

Subscribe

  • About Us
  • Contact
  • Privacy Policy
  • Terms of Use
  • Editorial Process

© 2025 All Rights Reserved - Global Finances Daily.

No Result
View All Result
  • Alternative Investments
  • Crypto
  • Financial Markets
  • Investments
  • Lifestyle
  • Protection
  • Retirement
  • Savings
  • Work & Careers

© 2025 All Rights Reserved - Global Finances Daily.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.